Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Melagatran

Copy Product Info
😃Good
Catalog No. T11994Cas No. 159776-70-2

Melagatran is an orally available, direct synthetic thrombin inhibitor that does not require endogenous cofactors other than thrombin and does not significantly interact with any other enzymes in the coagulation cascade or with the fibrinolytic enzymes.

Melagatran

Melagatran

Copy Product Info
😃Good
Purity: 99.83%
Catalog No. T11994Cas No. 159776-70-2
Melagatran is an orally available, direct synthetic thrombin inhibitor that does not require endogenous cofactors other than thrombin and does not significantly interact with any other enzymes in the coagulation cascade or with the fibrinolytic enzymes.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$540In StockIn Stock
5 mg$1,260In StockIn Stock
10 mg$1,630In StockIn Stock
25 mg$2,460In StockIn Stock
50 mg$3,290In StockIn Stock
100 mg$4,470-In Stock
1 mL x 10 mM (in DMSO)$1,190In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.83%
ee:100%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Melagatran AI Summary
Melagatran exhibits potent inhibitory activity against human thrombin with a Ki value of 2.0 nM and an IC50 value ranging from 4.7 to 4700 nM, depending on the assay conditions. It has a high binding affinity for thrombin, suggesting significant inhibitory effects on thrombin activity. In addition to thrombin, Melagatran demonstrates inhibition of other coagulation factors such as plasmin (IC50 = 3060.0 nM), trypsin (IC50 = 11.9 nM), factor IXa, and factor Xa (IC50 = 17300.0 nM), and exhibits antithrombin activity in both rats and dogs, with respective oral bioavailability F values of 5.2% and 24.0%. Pharmacokinetic studies indicate moderate volume of distribution, high fraction unbound in plasma, and moderate clearance rates in humans. It also demonstrates low oral bioavailability (3.0%) and low permeability across human Caco2 cells (Papp = 0.03 ucm/s). Additionally, Melagatran shows antiviral activity against SARS-CoV-2 but with a high IC50 (>20000 nM). Despite moderate inhibition of other targets like plasmin and tissue-type plasminogen activator, it remains a promising candidate for therapeutic applications related to anticoagulation..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Melagatran is an orally available, direct synthetic thrombin inhibitor that does not require endogenous cofactors other than thrombin and does not significantly interact with any other enzymes in the coagulation cascade or with the fibrinolytic enzymes.
In vivo
METHODS: To test the hypothesis that a regimen consisting of an oral thrombin inhibitor would delay or prevent occlusive clot formation, anesthetized dogs were given melagatran (1.5, 2.5 mg/kg) via nasogastric tube, and 15 minutes later, a potent thrombogenic stimulus in the form of an anodic current (100 μA) was applied to the intimal surface of the stenotic left anterior descending coronary artery (LAD).
RESULTS One of the dogs given high-dose melagatran did not develop thrombotic occlusion of the LAD during the entire 4-hour observation period. In the melagatran-treated dogs, coronary artery occlusions occurred during the observation period in 68% (low-dose) and 75% (high-dose) of the dogs.[2]
Chemical Properties
Molecular Weight429.51
FormulaC22H31N5O4
Cas No.159776-70-2
SmilesC([C@H](NCC(O)=O)C1CCCCC1)(=O)N2[C@H](C(NCC3=CC=C(C(=N)N)C=C3)=O)CC2
Relative Density.1.41 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 45 mg/mL (104.77 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3282 mL11.6412 mL23.2823 mL116.4117 mL
5 mM0.4656 mL2.3282 mL4.6565 mL23.2823 mL
10 mM0.2328 mL1.1641 mL2.3282 mL11.6412 mL
20 mM0.1164 mL0.5821 mL1.1641 mL5.8206 mL
50 mM0.0466 mL0.2328 mL0.4656 mL2.3282 mL
100 mM0.0233 mL0.1164 mL0.2328 mL1.1641 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Melagatran | purchase Melagatran | Melagatran cost | order Melagatran | Melagatran chemical structure | Melagatran in vivo | Melagatran formula | Melagatran molecular weight